Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit

被引:83
作者
Stone, PW
Gupta, A
Loughrey, M
Della-Latta, P
Cimiotti, J
Larson, E
Rubenstein, D
Saiman, L
机构
[1] New York Presbyterian Med Ctr, Sch Nursing, New York, NY USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA
[4] New York Presbyterian Med Ctr, Dept Pediat, New York, NY USA
[5] New York Presbyterian Med Ctr, Childrens Hosp New York, New York, NY USA
关键词
D O I
10.1086/502253
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: To determine the costs of the interventions aimed at controlling the 4-month outbreak and to determine the attributable length of stay (LOS) associated with infection and colonization with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. DESIGN: A retrospective cost analysis was conducted from the hospital perspective. A micro-costing approach was employed. The LOS of four groups of hospitalized patients were compared with each other. National Perinatal Information Center criteria were used to stratify infants for severity of risk. The LOS of each group was compared with that of a national sample of similarly stratified infants. SETTING: A level III-IV, 45-bed neonatal intensive care unit. PATIENTS: Infant groups were infected (n = 8), colonized (n = 14), concurrent cohort (n = 54), and prior cohort (n 486). RESULTS: The cost of the outbreak totaled $341,751. The largest proportion of costs was related to healthcare worker time providing direct patient care (2,489 hours at a cost of $146,331). Infected and colonized neonates had longer LOS than either the concurrent cohort or the prior cohort (P < .001). Compared with the national sample, infected infants had a 48.5-day longer mean LOS (95% confidence interval [CI95], 1.7 to 95.2), whereas the prior cohort's mean LOS was 6 days shorter (CI95,-9.4 to -2.9). CONCLUSIONS: This study increases the understanding of the burden of these multidrug-resistant organisms. Further research is needed to estimate the societal costs of these infections and the cost-effectiveness of preventive interventions.
引用
收藏
页码:601 / 606
页数:6
相关论文
共 39 条
[1]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[2]   Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey [J].
Astagneau, P ;
Fleury, L ;
Leroy, S ;
Lucet, JC ;
Golliot, F ;
Régnier, B ;
Brücker, G .
JOURNAL OF HOSPITAL INFECTION, 1999, 42 (04) :303-312
[3]  
CARDINALE VA, 1995, DRUG TOPICS RED BOOK
[4]  
*CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149
[5]   THE COST OF INFECTION IN SURGICAL PATIENTS - A CASE-CONTROL STUDY [J].
COELLO, R ;
GLENISTER, H ;
FERERES, J ;
BARTLETT, C ;
LEIGH, D ;
SEDGWICK, J ;
COOK, EM .
JOURNAL OF HOSPITAL INFECTION, 1993, 25 (04) :239-250
[6]  
Cofsky R, 2002, INFECT CONT HOSP EP, V23, P106, DOI 10.1086/502018
[7]   The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive cave unit [J].
DiGiovine, B ;
Chenoweth, C ;
Watts, C ;
Higgins, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :976-981
[8]   The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unit [J].
Dominguez, TE ;
Chalom, R ;
Costarino, AT .
CRITICAL CARE MEDICINE, 2001, 29 (01) :169-174
[9]   CHICKENPOX OUTBREAK AMONG THE STAFF OF A LARGE, URBAN ADULT HOSPITAL - COSTS OF MONITORING AND CONTROL [J].
FAOAGALI, JL ;
DARCY, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 1995, 23 (04) :247-250
[10]  
Flaherty JP, 1996, INFECT CONT HOSP EP, V17, P236